Boston, MA, United States
$160K – $200KMidFull Time
2 days agoView role
Vor Bio
Biotechnology Research2–10 employees
About
Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and commercialization to address serious autoantibody-driven conditions worldwide.